Eli Lilly and Company's Revenue by Region
In fiscal year , Eli Lilly and Company's revenue by geographical region are as follows:
Learn more about Eli Lilly and Company’s Revenue by Products
Check out competitors to Eli Lilly and Company in a side-by-side comparison.
Explore additional financial metrics for Eli Lilly and Company.
CHINA | 1452800000 |
---|---|
Europe | 4299200000 |
JAPAN | 1747300000 |
Other Foreign Countries | 2852000000 |
UNITED STATES | 18190000000 |
CHINA | 1539700000 |
---|---|
Europe | 6174700000 |
JAPAN | 1672600000 |
Other Foreign Countries | 2946200000 |
UNITED STATES | 21791000000 |
The above chart shows Eli Lilly and Company's revenue percentage share by geographical region.
In fiscal year 2022, Eli Lilly and Company's revenue by region is as follows:
- CHINA generated $1.45B in revenue, representing 5.09% of its total revenue.
- Europe generated $4.30B in revenue, representing 15.06% of its total revenue.
- JAPAN generated $1.75B in revenue, representing 6.12% of its total revenue.
- Other Foreign Countries generated $2.85B in revenue, representing 9.99% of its total revenue.
- UNITED STATES generated $18.19B in revenue, representing 63.73% of its total revenue.
The biggest region for Eli Lilly and Company is the UNITED STATES, which represents 63.73% of its total revenue.
The smallest region for Eli Lilly and Company is the CHINA, which represents 5.09% of its total revenue.
The above chart shows Eli Lilly and Company's revenue percentage share by geographical region.
In fiscal year 2023, Eli Lilly and Company's revenue by region is as follows:
- CHINA generated $1.54B in revenue, representing 4.51% of its total revenue.
- Europe generated $6.17B in revenue, representing 18.09% of its total revenue.
- JAPAN generated $1.67B in revenue, representing 4.9% of its total revenue.
- Other Foreign Countries generated $2.95B in revenue, representing 8.63% of its total revenue.
- UNITED STATES generated $21.79B in revenue, representing 63.86% of its total revenue.
The biggest region for Eli Lilly and Company is the UNITED STATES, which represents 63.86% of its total revenue.
The smallest region for Eli Lilly and Company is the CHINA, which represents 4.51% of its total revenue.
Summary Table
Geography (Percent Share) | 2022 | 2023 | 2024 |
---|---|---|---|
CHINA | 5.09% | 4.51% | 0% |
Europe | 15.06% | 18.09% | 0% |
JAPAN | 6.12% | 4.9% | 0% |
Other Foreign Countries | 9.99% | 8.63% | 0% |
UNITED STATES | 63.73% | 63.86% | 0% |
Total Revenue | 100% | 100% | 100% |
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
Region | 2022 | 2023 | 2024 |
---|---|---|---|
CHINA | $1.45B - |
$1.54B
5.98%
|
- - |
Europe | $4.30B - |
$6.17B
43.62%
|
- - |
JAPAN | $1.75B - |
$1.67B
4.28%
|
- - |
Other Foreign Countries | $2.85B - |
$2.95B
3.30%
|
- - |
UNITED STATES | $18.19B - |
$21.79B
19.80%
|
- - |
Total Revenue | $28.54B - |
$34.12B
19.56%
|
-
100.00%
|